![Thomas Lander](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di Thomas Lander
Precedenti posizioni note di Thomas Lander
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALLERGY THERAPEUTICS PLC | Direttore/Membro del Consiglio | 02/05/2012 | 30/06/2017 |
Independent Dir/Board Member | 02/05/2012 | 30/06/2017 | |
MERCK KGAA | Direttore Tecnico/Scientifico/R&S | 01/01/2003 | - |
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Direttore/Membro del Consiglio | 23/03/2011 | - |
Tuebingen Scientific Medical GmbH
![]() Tuebingen Scientific Medical GmbH Medical SpecialtiesHealth Technology Tuebingen Scientific Medical GmbH develops, produces and markets instruments and accessories for minimally invasive surgery. The company was founded by Marc O. Schurris in 2001 and is headquartered in Tübingen, Germany. | Corporate Officer/Principal | - | - |
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Corporate Officer/Principal | - | - |
NOVO NORDISK A/S | Corporate Officer/Principal | - | - |
Boehringer Ingelheim AB
![]() Boehringer Ingelheim AB Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany. | Corporate Officer/Principal | - | - |
Lipid Therapeutics GmbH
![]() Lipid Therapeutics GmbH Medical/Nursing ServicesHealth Services Lipid Therapeutics GmbH develops therapies for inflammatory diseases of the digestive system. Its product is LT-02, a delayed release of Phosphatidylcholine, for the treatment of Ulcerative colitis based on the preclinical and clinical work conducted by Prof. Stremmel from the University Hospital Heidelberg. The company was founded in 2008 and is headquartered in Heidelberg, Germany. | Direttore/Membro del Consiglio | 13/05/2010 | - |
Statistiche
Distribuzione geografica
Germania | 6 |
Svezia | 2 |
Danimarca | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
Independent Dir/Board Member | 1 |
Settori
Health Technology | 8 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
NOVO NORDISK A/S | Health Technology |
ALLERGY THERAPEUTICS PLC | Health Technology |
MERCK KGAA | Health Technology |
Aziende private | 5 |
---|---|
Lipid Therapeutics GmbH
![]() Lipid Therapeutics GmbH Medical/Nursing ServicesHealth Services Lipid Therapeutics GmbH develops therapies for inflammatory diseases of the digestive system. Its product is LT-02, a delayed release of Phosphatidylcholine, for the treatment of Ulcerative colitis based on the preclinical and clinical work conducted by Prof. Stremmel from the University Hospital Heidelberg. The company was founded in 2008 and is headquartered in Heidelberg, Germany. | Health Services |
Boehringer Ingelheim AB
![]() Boehringer Ingelheim AB Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany. | Health Technology |
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Tuebingen Scientific Medical GmbH
![]() Tuebingen Scientific Medical GmbH Medical SpecialtiesHealth Technology Tuebingen Scientific Medical GmbH develops, produces and markets instruments and accessories for minimally invasive surgery. The company was founded by Marc O. Schurris in 2001 and is headquartered in Tübingen, Germany. | Health Technology |
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Health Technology |
- Borsa valori
- Insiders
- Thomas Lander
- Esperienza